Study of recombinant human interleukin-12 for treatment of complications after radiotherapy for tumor patients

AIM: To evaluate the treatment effects of recombinant human interleukin-12 (rhIL-12) on radiotherapy complications, such as severe myelosuppression or pancytopenia, the decline or imbalance of immune function, etc. METHODS: The patients received high-dose and short-course precise radiotherapy, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Na, Wang, Wen-Qin, Gong, Xiao-Jing, Gao, Lei, Yang, Li-Rong, Yu, Wei-Na, Shen, Hong-Yu, Wan, Ling-Qin, Jia, Xi-Feng, Wang, Yi-Shan, Zhao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385437/
https://www.ncbi.nlm.nih.gov/pubmed/28439497
http://dx.doi.org/10.5306/wjco.v8.i2.158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385437/
https://www.ncbi.nlm.nih.gov/pubmed/28439497
http://dx.doi.org/10.5306/wjco.v8.i2.158

Ejemplares similares